Signaling Pathways
A basic property of living systems is the ability to respond to extracellular signals by evoking an internal response. Signal-transduction cascades mediate the sensing and processing of these stimuli. These molecular circuits detect, amplify, and integrate diverse external signals to generate responses such as changes in enzyme activity, gene expression, phenotypic alterations, or ion-channel activity. Signal-transduction pathways follow a broadly similar course that can be viewed as a molecular circuit. Upon an environmental signal, Membrane receptors transfer information from the environment to the cell's interior. Subsequently, second messengers relay information from the receptor-ligand complex into the cell's interior. Particularly important second messengers include cyclic AMP and cyclic GMP, calcium ion, inositol 1,4,5-trisphosphate, (IP3), and diacylglycerol. While these second messengers are free to move, they can easily diffuse to other compartments of the cell, such as the nucleus, where they can influence gene expression and other processes. Interestingly, signal transduction may be amplified significantly in the generation of second messengers, since initial stimulation may lead to the generation of many second messengers within the cell. Thus, a low concentration of signal in the environment, even as little as a single molecule, can yield a large intracellular signal and response. Besides this phenomenon, cross-talk between two or more signaling cascades may occur, which permits more finely tuned regulation of cell activity than would the action of individual independent pathways[1]
[1] Signal-Transduction Pathways: An Introduction to Information Metabolism. Biochemistry. 5th edition. J.M. Berg, J.L.Tymoczko, L. Stryer.New York, 2002.
Axon ID | Name | Description | From price | |
---|---|---|---|---|
1378 | AG 490 | JAK2 inhibitor | €65.00 | |
1778 | AZ 960 | JAK2 inhibitor | €95.00 | |
3855 | AZD-4205 | Selective and ATP-competitive inhibitor of JAK1 | Inquire | |
1955 | Baricitinib | Inhibitor of JAK1 and JAK2 | €70.00 | |
3813 | BMS-911543 | Potent, selective and orally active inhibitor of JAK2 | Inquire | |
3671 | CEP-33779 | Potent, selective and orally bioavailable JAK2 inhibitor | €95.00 | |
1338 | CP 690550 | JAK3 inhibitor | €60.00 | |
3861 | Decernotinib | Potent and selective,orally bioavailable Janus kinase 3 (JAK3) inhibitor | Inquire | |
4006 | GLPG-0634 | The first orally-available, selective inhibitor of JAK1 | Inquire | |
1843 | JAK2 inhibitor 13 | JAK2 inhibitor | €110.00 | |
2554 | LY 2784544 | Potent, selective and ATP-competitive inhibitor of mutated janus kinase 2 (JAK2V617F) | €95.00 | |
1681 | Momelotinib | JAK1 and JAK2 inhibitor | €80.00 | |
4124 | Momelotinib hydrochloride | JAK1 and JAK2 inhibitor | €120.00 | |
2792 | NVP-BSK805 | Potent, selective and orally bioavailable JAK2 inhibitor | €125.00 | |
3950 | Peficitinib | Potent and orally bioavailable JAK inhibitor | €120.00 | |
2217 | PF 956980 | JAK3 inhibitor; analogue of Axon 1338 and 2072 | €90.00 | |
1598 | Ruxolitinib | JAK1 and JAK2 inhibitor | €65.00 | |
2539 | Solcitinib | Selective JAK1 inhibitor for treatment of degenerative and inflammatory diseases | €90.00 | |
1588 | TG 101348 | JAK2 inhibitor | €80.00 | |
2072 | Tofacitinib citrate | Potent Janus Kinase 3 (JAK3) inhibitor | €115.00 | |
2316 | WP 1066 | Potent JAK2 and STAT3 inhibitor and downregulator of antiapoptotic proteins | €95.00 | |
2231 | XL 019 | JAK2 inhibitor | €100.00 |